Advanced Search

Technical Analysis for OPT - Opthea Limited

Grade Last Price % Change Price Change
F 12.33 -3.37% -0.43
OPT closed down 3.37 percent on Friday, January 15, 2021, on 11 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Up
Historical OPT trend table...
Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Crossed Above 50 DMA Bullish -3.37%
Above Upper BB Strength -3.37%
Upper Bollinger Band Touch Strength -3.37%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.90%
Narrow Range Bar Range Contraction 1.90%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.75%
Down 3 Days in a Row Weakness 2.75%
Older End-of-Day Signals for OPT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago
Fell Below 50 DMA 1 day ago
Fell Below Upper Bollinger Band 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

  • Earnings date: ???
Opthea Limited operates as a biotechnology company. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.
Classification
Sector: Other
Industry: Other
Keywords: Medicine Biotechnology Eye Organ Systems Diabetes Healthcare Providers Ophthalmology Diabetic Retinopathy Macular Edema Transplantation Blindness Eye Disease Diabetic Macular Edema Cornea Angiology Dry Eye Disease

Is OPT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Dec 29 The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica
Dec 16 The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
Nov 8 The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Oct 21 Loss-Making Opthea Limited (ASX:OPT) Expected To Breakeven In The Medium-Term
Oct 16 Opthea prices U.S. IPO
Oct 13 Opthea to raise $160M in IPO
Oct 12 Opthea Readies Plan For U.S. IPO
See more OPT news...

Indicators

Indicator Value
52 Week High 21.36
52 Week Low 0.0
Average Volume 17,745
200-Day Moving Average 0.00
50-Day Moving Average 12.40
20-Day Moving Average 11.80
10-Day Moving Average 12.14
Average True Range 0.73
ADX 5.93
+DI 28.35
-DI 20.12
Chandelier Exit (Long, 3 ATRs ) 10.82
Chandelier Exit (Short, 3 ATRs ) 12.86
Upper Bollinger Band 12.74
Lower Bollinger Band 10.86
Percent B (%b) 0.78
BandWidth 15.94
MACD Line -0.02
MACD Signal Line -0.16
MACD Histogram 0.1488
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.93
Resistance 3 (R3) 12.96 12.80 12.83
Resistance 2 (R2) 12.80 12.64 12.78 12.80
Resistance 1 (R1) 12.56 12.55 12.68 12.53 12.76
Pivot Point 12.40 12.40 12.45 12.38 12.40
Support 1 (S1) 12.16 12.24 12.28 12.13 11.90
Support 2 (S2) 12.00 12.15 11.98 11.86
Support 3 (S3) 11.76 12.00 11.83
Support 4 (S4) 11.73